NEW YORK CITY, NY / ACCESS Newswire / February 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...

Learn more about whether Glaukos Corporation or Inari Medical, Inc. is a better investment based on AAII's A+ Investor grades ...

Inari Medical, Inc. NARI is well-poised for growth on the back of a huge market opportunity for its products and its commitment to understanding the venous system. However, the company’s dependency on ...

Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

Learn more about whether Inari Medical, Inc. or DENTSPLY SIRONA Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Inari Medical Inc (NARI) stock saw a modest uptick, ending the day at $79.74 which represents a slight increase of $0.28 or 0.35% from the prior close of $79.46. The stock opened at $79.54 and touched ...

On Tuesday, Inari Medical Inc (NARI) stock saw a decline, ending the day at $79.5 which represents a decrease of $-0.05 or -0.06% from the prior close of $79.55. The stock opened at $79.54 and touched ...

Inari Medical (TASE:PMCN) Inc. (NARI) has reached a new 52-week high, with its stock price climbing to $79.7, marking a significant milestone for the $4.68 billion medical device company.

Inc. (NARI) has reached a new 52-week high, with its stock price climbing to $79.7, marking a significant milestone for the ...

After two consecutive years of 20%-plus gains, the S&P 500 kicked off 2025 with a solid January performance. Investors are hoping the S&P 500 can continue to grind higher and maintain its ...

Finally, Glenn will offer further details on our 2024 results and 2025 guidance as well as financial elements Inari Medical and Spine before we open the call to Q&A. First, as you saw in our press ...

We recently compiled a list of the 10 Hottest Mid-Cap Stocks So Far in 2025. In this article, we are going to take a look at ...